1. 100PConcordance between tissue analysis (TA) and liquid biopsy (LB) for RAS/BRAF and the optimization of its clinical application in such a heterogeneous tumour. (7th November 2019) Authors: Grilo, I; Leite, R; Gago, P; Duarte, S; Teira, A; Sarmento, T; Sousa, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Facing treatment of non-urothelial bladder cancers in the immunotherapy era. (September 2020) Authors: Grilo, I; Rodrigues, C; Soares, A; Grande, E Journal: Critical reviews in oncology/hematology Issue: Volume 153(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P-194Right vs left-sided RAS wild-type metastatic colorectal cancer treated with EGFR inhibitors: prognostic differences. (2nd July 2019) Authors: Duarte, S; Grilo, I; Ladeira, K; Pimenta, J; Liu, P; Sarmento, T; Barbosa, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗